ABC Maintenance Therapy for AML

Inclusion criteria

• ✓. Patients aged 18 to 80 years with newly diagnosed Acute Myeloid Leukemia (AML)
• ✓. Patients who have achieved their first Complete Remission (CR) or Complete Remission with incomplete hematologic recovery (CRi) at the time of enrollment, following induction therapy with intensive chemotherapy and at least 2 cycles of consolidation therapy. Remission must have been achieved within 4 months (±7 days) prior to enrollment.
• ✓. Eastern Cooperative Oncology Group (ECOG) performance status ≤ 3.
• ✓. Women of childbearing potential are eligible if they meet the following conditions:
• ✓. A negative serum or urine pregnancy test is performed within 10-14 days prior to enrollment, and a second negative pregnancy test is performed within 24 hours prior to the initiation of treatment. Both negative results are required to meet the criteria for treatment initiation.
• ✓. They agree to practice abstinence or use two effective methods of contraception during the treatment period and for 28 days after discontinuation of the study drug.
• ✓. Male patients with female partners of childbearing potential are eligible if they agree to practice abstinence or use two effective methods of contraception during the treatment period and for 28 days after discontinuation of the study drug.